Communication Skills Intervention to Promote Transition Into Survivorship
Running, not enrolling
Conditions studied: Hodgkin's Lymphoma, Diffuse Large B-cell Lymphoma
In brief
The purpose of this study is to improve the communication skills of physicians who transition lymphoma cancer patients from the end of treatment to survivorship.
Key facts
- Study ID
- NCT01483664
- Run by
- Memorial Sloan Kettering Cancer Center
- People needed
- 314
- Starts
- 2011-11-01
- Expected to finish
- 2026-11-01
- Last updated by the study team
- 2026-01-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Physicians:
- who treat patients with DLBCL and HD as per self report
- Patients of Physicians:
- have a new diagnosis of Hodgkin's or Diffuse Large B-cell Lymphoma as per pathology report or physician assessment in medical record and/or clinical judgment of the treating physician treated with curative intent.
- For part 1 - have scans indicating remission and completing planned chemotherapy and/or radiation therapy. The treating physician will determine that clinical remission has been achieved based on their best judgment.
- For part 2 (longitudinal phase): - have new scans indicating remission and completing planned chemotherapy and/or radiation therapy. The treating physician will determine that clinical remission has been achieved based on their best judgment.
- be at least 18 years old
- speak English well enough, in the judgment of the consenting professional, to be able to understand all aspects of the study, provide informed consent, and be able to complete all study measures.
You may not qualify if…
- Physicians:
- who do not have adequate patients in their clinical practice to meet the 8 patient enrollment requirement for patients with either DLBCL or HD as per self report
- Patients of Physicians:
- show evidence of cognitive impairment severe enough to preclude giving permission to the study staff, or completing the survey instruments of the study.
- as per physician judgment, patient's prognosis and/or co-morbidities make them inappropriate for participation in a survivorship study.
- For Part 2 ONLY (longitudinal phase):
- those who consented to part 1, consult recording, of the study.
Where it is running
- Tampa General Hospital — Tampa, Florida, United States
- Moffitt Cancer Center — Tampa, Florida, United States
- Memorial Sloan Kettering at Basking Ridge — Basking Ridge, New Jersey, United States
- Maimonides Medical Center — Brooklyn, New York, United States
- Memorial Sloan Kettering Cancer Center at Commack — Commack, New York, United States
- Memorial Sloan Kettering Cancer Center — New York, New York, United States
- Memorial Sloan Kettering Cancer Center at Mercy — Rockville Centre, New York, United States
- Memorial Sloan Kettering Cancer Center at Phelps — Sleepy Hollow, New York, United States
- Md Anderson Cancer Center — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.